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In today's neurodevelopment and -disease research, human neural stem/progenitor cell-derived net-
works represent the sole accessible in vitro model possessing a primary phenotype. However, cultivation
and moreover, differentiation as well as maturation of human neural stem/progenitor cells are very
complex and time-consuming processes. Therefore, techniques for the sensitive non-invasive, real-time
monitoring of neuronal differentiation and maturation are highly demanded.
Using impedance spectroscopy, the differentiation of several human neural stem/progenitor cell lines
was analyzed in detail. After development of an optimum microelectrode array for reliable and sensitive
long-term monitoring, distinct cell-dependent impedimetric parameters that could speciﬁcally be as-
sociated with the progress and quality of neuronal differentiation were identiﬁed. Cellular impedance
changes correlated well with the temporal regulation of biomolecular progenitor versus mature neural
marker expression as well as cellular structure changes accompanying neuronal differentiation. More
strikingly, the capability of the impedimetric differentiation monitoring system for the use as a screening
tool was demonstrated by applying compounds that are known to promote neuronal differentiation such
as the γ-secretase inhibitor DAPT.
The non-invasive impedance spectroscopy-based measurement system can be used for sensitive and
quantitative monitoring of neuronal differentiation processes. Therefore, this technique could be a very
useful tool for quality control of neuronal differentiation and moreover, for neurogenic compound
identiﬁcation and industrial high-content screening demands in the ﬁeld of safety assessment as well as
drug development.
& 2016 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
In recent years, human pluripotent stem cells have emerged as
a promising cell resource for generating high quality human cell
types by speciﬁc differentiation. Especially for the development of
neuronal tissue models in the context of in vitro cell-based assays
for e.g. drug screening pluripotent stem cells are promising. SinceB.V. This is an open access article u
(A.A. Robitzki).there is no broad access to primary neurons of human origin for
standardized assays, recent in vitro research relies on im-
mortalized neuronal cell lines that are expandable, homogenous
and reproducible. However, these cells often do not resemble na-
tive neuronal function in terms of metabolism and activity (Ebert
and Svendsen, 2010). Pluripotent stem cells are able to overcome
these limitations allowing the reproducible generation of highly
proliferative neuronal precursors that can easily be differentiated
in manageable time intervals to mature in vivo-like neuronal
networks (Falk et al., 2012). Dependent on the application, thender the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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subtype) can be speciﬁed. Therefore, a number of protocols for the
generation of renewable neural stem and progenitor cells with
restricted proliferation capacity are available (Falk et al., 2012;
Koch et al., 2009; Li et al., 2011; Nemati et al., 2011).
To monitor neurodevelopment, to identify neurogenic as well
as toxic compounds and to improve neuronal differentiation pro-
tocols, non-invasive bioanalytical techniques are highly demanded
to quantitatively track the process of neuronal differentiation.
Besides time-consuming conventional molecular biological meth-
ods mainly restricted to end-point analysis, some techniques have
emerged that allow the fast and real-time study of differentiating
cell lines. However, these technologies are mostly dependent on
labels or single cell applications that do not comprise the analysis
of a complex developing neuronal network (Leao et al., 2010; Mir
and Shinohara, 2013).
Combining microelectrode arrays (MEAs) and electrochemical
impedance spectroscopy (EIS), we wanted to overcome these
limitations. EIS is an innovative technique that is broadly used for
label-free and real-time monitoring in biosensors (Katz and Will-
ner, 2003; Ong et al., 2001). Complex cellular processes such as cell
death/degeneration (Jahnke et al., 2012, 2013b; Poenick et al.,
2014; Seidel et al., 2012), motility (Haas et al., 2010) and signaling
in single cells and multi-dimensional structures in vitro and in vivo
(Jahnke et al., 2013a) can be analyzed.
In the context of differentiation monitoring, EIS has been used
to discriminate pluripotent stem cells and derived cell types such
as osteoblasts, adipocytes and neurons over a limited time range of
hours till days (Bagnaninchi and Drummond, 2011; Park et al.,
2011). Based on their distinct dielectric properties, the separation
of matured from progenitor cells or even degenerate from native
cells in single cell suspensions by di-electrophoresis is a further
application of EIS (Flanagan et al., 2008; Hosseini et al., 2016; Song
et al., 2015). However, all these studies did not concentrate on the
detailed correlation of cellular/subcellular dielectric characteristics
to the unique structural and molecular alterations that differ-
entiating cells undergo during their maturation over weeks or
months.
This study describes the use of a novel MEA-supported EIS
platform for the sensitive and quantitative label-free monitoring
of the complete differentiation process from progenitor cells
to neuronal networks over more than 30 days and without
the destruction of the adherent, maturating neuronal network
structures.2. Material and methods
2.1. Cell lines and culture
Primitive neuronal progenitor stem cells (pNSC) 1 and 2 were
derived from the human induced pluripotent stem cell (hiPS) lines
IMR90c01 and 31f-r1 according to the protocol developed by Li
et al. (2011). IMR90c01 and 31f-r1 hiPS generation is listed in Table
S1. Cell lines were obtained from Coriell Institute for Medical Re-
search (IMR90c01) and University of Bonn, Medical Center (iLB-C-
31f-r1). The long-term neuroepithelial-like (lt-NES) cell line was
derived from H9.2 human embryonic stem cells (hES) as pre-
viously described (Koch et al., 2009) and kindly provided by the
University of Bonn, Medical Center. pNSC lines were clearly iden-
tiﬁed as neuronal precursors by typical marker expression (Sup-
plementary Fig. S1). Cells were maintained, differentiated and
marker expression was characterized as explained in the Supple-
mentary Methods.2.2. Microelectrode fabrication
Microelectrode arrays were produced in our clean room facility
by standard lift-off techniques. Detailed procedure, see Supple-
mentary Methods.
2.3. EIS
Cells were grown on 0.3 mg/ml Matrigel-coated MEAs till
conﬂuence. Impedance spectra were recorded with the self-
developed 378-channel (9w42e MEA) or 60-channel multi-
plexer board (1w54e; 9w6e MEA) in combination with the high
precision impedance analyzer ISX-3 (ScioSpec Scientiﬁc Instru-
ments GmbH). Cellular impedance was measured applying 10 mV
alternating voltage in a frequency interval ranging from 500 Hz to
5 MHz (41 frequency points) (measurement setup see Supple-
mentary Fig. S2). For analysis, relative impedance (|Z|rel)
was calculated from the impedance of the cell-covered (|Z|cell)
and cell-free electrode (|Z|blank) based on the equation
|Z|rel (%)¼(|Z|cell |Z|blank)/|Z|blank100. Low initial relative im-
pedance values of o80% (not/only partially cell-covered electro-
des) were automatically excluded from all following measure-
ments within the differentiation process to guarantee the detec-
tion of only the cellular impedance signal. Maximal relative im-
pedance was traced over time and normalized to measurement
start (undifferentiated neural progenitor state; 100%) to allow the
statistical analysis of the differentiation-speciﬁc impedance prop-
erties. For relative impedance spectrum post-maximum slope
(PMS) analysis see Supplementary Methods.
2.4. Equivalent circuit modeling
For in depth analysis of impedance spectra alterations, mag-
nitude and phase angle spectra were ﬁtted based on an electronic
equivalent circuit model for the tissue–electrode interface (see
Results section) (Jahnke et al., 2012). The culture medium re-
sistance (RMed) was considered as constant (70 Ω). Parameters of
the equivalent circuit were determined in a two-step optimization
procedure. First, the MEA-speciﬁc constant phase element (CPEEL)
and the measurement system resistance (RSys) were calculated
using a reduced equivalent circuit without the cell-speciﬁc para-
meters cell membrane/intercellular capacitance (CCell) and re-
sistance (RCell) as well as extracellular resistance (RExtra) by the
acquired spectra of cell- and coating-free MEAs. Subsequently, the
cell-covered electrodes were analyzed by applying the entire
equivalent circuit. At this step, the system and the previously ob-
tained electrode-dependent parameters were kept constant. Only
CCell and RCell as well as RExtra were determined by the ﬁtting
procedure. For ﬁtting the self-developed impedance data analysis
software IDAT v3.6.5.2 was used.
2.5. Statistical analysis
All statistical analyzes were done using GraphPad Prism 5. All
values are shown as means7s.e.m. unless described differentially.
Multiple group comparisons were analyzed by two-way ANOVA
and Bonferroni post hoc test. Comparisons between two groups
were analyzed by t-test. Differences between two means with
po0.05 were considered signiﬁcant (*), po0.01 very signiﬁcant
(**) and po0.001 highly signiﬁcant (***).
Correlation coefﬁcients of multiple method data progression
was determined applying two-tailed Pearson correlation and col-
or-coded with red (rare correlationo0.5), yellow (medium cor-
relation 0.5–0.75), light green (strong correlation 0.75–0.9) and
green (very strong correlation40.9). Inverse correlations are
shown as absolute values.
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3.1. Reliable and sensitive impedimetric monitoring of neural plur-
ipotent stem cell differentiation by an optimized biochip layout
To ensure the reliable and sensitive detection of cellular im-
pedance changes, a MEA with high electrode density, small elec-
trode size and a highly hydrophilic surface had to be designed,
especially since previous MEA layouts with only six electrodes per
culture unit/well seemed to be insufﬁcient for long-term neuronalFig. 1. Neuronal differentiation of neural progenitors led to speciﬁc cellular impedan
(a) 1w54e MEA and (b) 9w42e MEA at day 0 and 15 (black semi-circle represents half an
dependent maximal relative impedance progression (right diagram) of differentiating p
and 9w42e impedance measurement features. (n¼3 experiments).differentiation monitoring (Supplementary Fig. S3). Based on these
demands, two novel MEA designs were tested, which varied in
electrode and culture surface layout (Fig. 1a). In order to optimize
cell adherence, the passivation layer (SU8 polymer) had to be
optimized by plasma treatment before each cell seeding. We could
show that neuronal cell growth on MEA was only affected by the
SU8-coating modiﬁcation but independent of the electrode dia-
meter and surface area making both MEA types suitable for
homogenous monolayer cultures (Fig. 1a and b).ce changes that can best be detected using the 9w42e MEA. pNSC1 cultured on
electrode); scale 50 mm. Quantitative analysis of time- (left diagram) and frequency-
NSC1 on the (c) 1w54e and (d) 9w42e MEA. (e) Quantitative comparison of 1w54e
D. Seidel et al. / Biosensors and Bioelectronics 86 (2016) 277–286280In addition to the differentiation-speciﬁc relative impedance
characteristics (Supplementary Fig. S2c) that could be identiﬁed
with both MEA types (Fig. 1c and d vs. Supplementary Fig. S4),
technique-dependent impedance properties were investigated
(Fig. 1e). For the 9w42e (nine wells with 42 measurement elec-
trodes each) MEA, an optimal maximal relative impedance at
measurement start (270.5722.9%) as well as a very low overall
signal variance (2.170.1%) could be detected that is signiﬁcantly
better in comparison to the 1w54e (one well with 54 measure-
ment electrodes; 227.1717.9%; 3.070.1%; po0.05) and moreover,
to the 9w6e (nine wells with six measurement electrodes each)
MEA (Supplementary Fig. S3; 198.3737.3%; 34.674.4%;
po0.001). Additionally, the high number of analyzable electrodes
per MEA (224733), in comparison to the 1w54e MEA (2973),
together with its multiwell-format classiﬁed the 9w42e MEA as
the most suitable for reliable and sensitive differentiation
monitoring.
To validate the bioelectronics platform, two distinct and well-
characterized self-renewing and highly neurogenic neural stem/
progenitor populations were used (Koch et al., 2009; Li et al.,
2011). Namely, these were a rosette-type H9.2 hES-derived lt-NES
cell line and two pre-rosette-type, primitive neuroepithelial stem
cell lines (pNSC1; pNSC2) derived from different hiPS lines (Sup-
plementary Table S1; (Koch et al., 2009)). Differentiation of cells
treated with neuronal differentiation medium (NDM) was mon-
itored over a period of 30 days in comparison to the control group
cultivated in neuronal progenitor medium (NPM). During differ-
entiation, a conﬂuent cell layer developed on the electrodes al-
lowing EIS monitoring (Fig. 2a). Relative impedance progressionFig. 2. Quantitative impedimetric characterization of neural precursor cell line differe
impedance progression, (c) PMS of relative impedance spectra at day 14 of differenti
precursors. (n¼3 experiments).over time revealed signiﬁcant different traces for proliferating and
differentiating cells (Fig. 2b). Generally, NPM-treated precursors
were characterized by increasing relative impedance values (70–
100%), whereas application of NDM induced a progressive de-
crease by 30–70% dependent on the used precursor population.
To investigate the EIS platform's capability for speciﬁc neuronal
differentiation monitoring, further parameters as the relative im-
pedance spectrum shape and relative impedance maximum fre-
quency shifts (Fig. S2c) were analyzed that recently were found to
be tissue/cell type-dependent (Dean et al., 2008; Heileman et al.,
2013). More strikingly, Jahnke and colleagues could show that
neural tissue in vivo is characterized by a relative impedance
spectrum exhibiting a speciﬁc ﬂattened PMS (Jahnke et al., 2013a).
Here, we could identify a similar signiﬁcant PMS decrease (3–17
fold) in all precursor lines applying NDM instead of NPM for 14
days (Fig. 2c) with values of 3.471.0 for pNSC2 that was com-
parable to pNSC1 (4.570.6) and 11.674.8 for differentiated lt-
NES.
As a third parameter, the frequency, where maximal relative
impedance could be observed, was analyzed (Supplementary Fig.
S2c), since previous studies indicated that cell phenotype switches
correlate with a frequency change (Haas et al., 2010). Whereas
application of NPM never led to a signiﬁcant frequency shift, NDM
treatment induced a signiﬁcant shift of the relative impedance
spectrum to higher frequencies for all three reference cell lines
(Fig. 2d; lt-NES: 95.277.3%; pNSC1: 288.4741.1; pNSC2:
203.674.5%).
Based on these empirical observations, the differentiation
process is reﬂected in an alteration of distinct impedancentiation. (a) Cell coverage of electrodes; scale 50 mm, (b) time-dependent relative
ation and (d) relative frequency shift of maximal relative impedance of different
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pical morphological changes associated with neuronal differ-
entiation. Thus, the impact of cell-dependent elements (mem-
brane, cell-cell-contacts, intercellular space etc.) that directly in-
ﬂuence the measured impedance was analyzed.
3.2. Equivalent circuit-derived parameters that reﬂect the neuronal
differentiation process
We performed an equivalent circuit-based (Fig. 3a) ﬁtting of
the magnitude and phase angle spectra (Fig. 3b) resulting in dis-
tinct values for the parameters RCell, CCell and RExtra. In this context,
RCell reﬂects the cell membrane resistance and the intercellular
resistance, CCell the cell membrane capacitance and RExtra an ex-
tracellular resistance caused by e.g. the extracellular matrix. As
monitoring was done over two weeks, in which considerable
changes in cell-cell contacts occur, RCell is dominated by the in-
tercellular resistance.
For progressive neuronal differentiation, a continuous decrease
of RCell was observed over time (Fig. 3c). This was caused by the
changing morphology of developing neurons forming long pro-
cesses, which led to increased intercellular space within the net-
work, and by reduced tight cell-cell contacts accompanying pro-
genitor-to-neuron transition (Kornberg and Roy, 2014). In contrast,
RCell of the control (NPM) increased until day 8 followed by a
decrease till day 14 to values still higher than found at day 0. This
can be correlated with a cell layer where proliferation led to in-
creased density without free space between cells closely con-
nected by tight junctions (Li et al., 2011). However, when cells get
more and more compressed, number of cells and therewith small
intercellular spaces per electrode are increased again causing de-
creased RCell.
More interesting, the cell membrane capacitance CCell (Fig. 3c)
showed no signiﬁcant changes for the control group (NPM), but
was signiﬁcantly increased for NDM-treated cells fromFig. 3. Cell type-speciﬁc dielectric properties can be determined applying a simpliﬁed eq
(b) Example of the recorded impedance magnitude (|Z|) and phase angle spectra that wer
(El). (c) Analysis of cell-speciﬁc parameters RCell, CCell and RExtra after pNSC2 treatmentdifferentiation day 6 on. This ﬁnding correlates with an increased
amount of cell membrane located on the measurement electrode.
In combination with the decreased cellular resistance (i.e. in-
creased intercellular space), this can be explained by a distinct
increase in the ratio of cell membrane to cell volume as it occurs
during neuronal process formation.
Furthermore, the extracellular matrix had a contribution to the
measured impedance most probably caused by the insulating
Matrigel coating. Differentiation led to a continuously decreased
RExtra that may be due to forced Matrigel degradation, while for
the NPM-treated group values did not change signiﬁcantly
(Fig. 3c).
Taken together, the equivalent circuit analysis revealed speciﬁc
changes in parameters that strictly correlate with the intercellular
resistance and the cell membrane capacitance, morphology ele-
ments that are typically modiﬁed during neuronal differentiation.
Additionally, we could show that the used precursor populations
exhibited different impedimetric propensities during differentia-
tion. Whereas the pNSC lines generated via the same protocol
resembled each other, lt-NES were characterized by a different
impedance proﬁle.
In order to validate the EIS platform, the correlation of the
impedimetric data with molecular differentiation markers was
analyzed.
3.3. Correlation of molecular differentiation markers and EIS
parameters
The microscopic morphology analysis showed that, with in-
creasing differentiation time, cell density decreased, cell body
volume was reduced and long cell processes became visible
(Fig. 4a, arrows). As well-characterized speciﬁc markers for de-
veloping neurons, neuroﬁlament 200 (NF200) and light neuroﬁ-
lament (NF-L) were analyzed. An increasing number of cells with
neuronal phenotype could be identiﬁed over time (Fig. 4b, arrows).uivalent circuit model. (a) Schematic representation of the equivalent circuit model.
e mathematically ﬁtted using the electrode spectra with (ElþCell) and without cells
with NPM or NDM for 14 days. (n¼3 MEAs).
Fig. 4. Identiﬁed cell-dependent impedimetric parameters correlate with the state and quality of neuronal differentiation. (a) Morphological characterization,
(b) immunocytochemical staining of the neuronal marker protein NF200 (green). Arrows point on pronounced neuronal processes; scale 50 mm. (c) Quantitative gene and
(d) protein expression analysis of the neural differentiation marker NF-L. (n¼3 experiments) (e) Analysis of time- and method-dependent data correlation coefﬁcients. Bold
black-framed values represent correlation coefﬁcients of impedance-based parameters to NF-L protein expression. (For interpretation of the references to color in this ﬁgure
legend, the reader is referred to the web version of this article).
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with the signiﬁcantly highest frequency shift after 30 day long-
term differentiation (Fig. 2d; Fig. 4b right, Fig. 4d).
The observed differentiation-dependent alterations in cell
morphology and NF-L expression were further quantiﬁed via gene
expression and ﬂuorescence intensity analysis (Fig. 4c and d). In
contrast to the neuroﬁlament immunostaining, for lt-NES and
pNSC1 cells no signiﬁcant increase of basal NF-L messenger ribo-
nucleic acid (mRNA) level could be observed over the 40 day dif-
ferentiation period. This is in accordance with a prior study
(Beaudet et al., 1993). The NF-L protein expression quantiﬁcation
revealed comparable values for all differentiated precursor lines
for 20 and 40 days of differentiation indicating an equalization of
differentiation states over time as it was also visible in the PMS
analysis (Fig. 3c).
To further validate a typical neural differentiation process, we
characterized progenitor marker gene and protein expression
(Supplementary Fig. S5a and b) and found a typical initial increase
of Nestin and Paired box 6 (Pax6) followed by repression till day40 for the pNSCs. Dependent on the later developmental state, lt-
NES showed a decreased Pax6 protein expression, whereas Nestin
expression was comparable. Furthermore, the speciﬁc progenitor
population phenotype was validated via glial ﬁbrillary acidic pro-
tein (GFAP) and S100 astrocyte marker analysis, which is typical
for pNSC but not lt-NES maturation at late differentiation states
(Supplementary Fig. S5b and c) (Koch et al., 2009; Li et al., 2011).
To quantify the observed coherency of molecular- and im-
pedance-based data, correlation coefﬁcients were determined and
a clear accordance for pNSC1 between NF-L protein and mRNA
expression as well as impedimetric parameters (0.96oro1.00)
was found (Fig. 4e). For pNSC2, a clear correlation exists for the
NF-L protein expression and the impedimetric parameters
(0.94oro1.00). lt-NES differentiation revealed a clear correlation
for the NF-L protein expression, the relative impedance maximum
and frequency shift (0.95oro1.00).
Based on the reference cell lines that are known for their
neurogenic potential, proved by NF-L protein expression analysis,
a high correlation with the impedimetric parameters was
D. Seidel et al. / Biosensors and Bioelectronics 86 (2016) 277–286 283identiﬁed (Fig. 4e, bold black boxes). This validates the reliability
for impedimetric neuronal differentiation monitoring especially
when all three parameters were taken into account.
3.4. Quantitative impedimetric monitoring of neuronal differentia-
tion acceleration
In order to demonstrate that the impedimetric platform can be
used for screening of neurogenic compounds, the γ-secretase in-
hibitor DAPT was tested, which is well-characterized to accelerate
initial neuron differentiation via the blockage of Notch signaling
(Borghese et al., 2010).
To speciﬁcally visualize DAPT-dependent effects, all values
were normalized to the non-treated control (ctrl, NDM). Based on
the impedimetrically determined EC50 values, a DAPT effect on all
neural precursor lines was visible (Fig. 5a). For lt-NES, a signiﬁcant
decrease of the initial high EC50 of 4.670.4 mM to 1.470.2 mMwas
observed. A 10 day DAPT application induced similar values that
pNSCs already reached at day 5 (pNSC1: 0.670.2 mM, po0.05;
pNSC2: 1.770.3 mM). For pNSCs, EC50 analysis revealed an insig-
niﬁcant increase over time and therewith probably a shorter ef-
fective time course. Furthermore, DAPT had a higher impact on
pNSC1 than on pNSC2, which was revealed by higher EC50 values.
Interestingly, we only found a clear DAPT effect for the lt-NESFig. 5. DAPT-mediated neuronal differentiation acceleration can be monitored selective
based EC50 quantiﬁcation, (b) relative frequency shift, (c) quantiﬁcation of impedance sand pNSC1 line, whereas pNSC2 cells showed no frequency shift
change when treated with nano- and micromolar DAPT con-
centrations (Fig. 5b). Application of 2.5 mM DAPT induced a sig-
niﬁcantly (po0.01) increased frequency shift of pNSC1 already at
day 5. For a 10-day application of 2.5 mM DAPT, lt-NES and pNSC1
showed comparable frequency shifts of 190% (po0.001) that for
lt-NES remained stable till day 20 (177.078.5%), whereas at that
time pNSC1 did not react signiﬁcantly different compared to the
control. This further supports the different impact of DAPT on the
two precursor populations.
Based on the strong effect of 2.5 mM DAPT, the PMS analysis
was done for this concentration (Fig. 5c). The described DAPT
sensitivity of lt-NES and pNSC1 could be validated, since DAPT
application induced a signiﬁcant decrease of PMS for all time
points. However, highest effect was detected at day 20 for lt-NES
(21.877.6%), but already at day 5 for pNSC1 (5.474.5%). In con-
trast, pNSC2 showed signiﬁcantly decreased values for day 5 that
aligned to the control for prolonged DAPT treatment indicating a
very fast DAPT effect but an insensitivity for long-term application.
For the comparison of EIS-based data with differentiation-
speciﬁc molecularbiological changes, the correlation of DAPT-de-
pendent induction of NF-L and impedance progression was
analyzed.ly by differentiation-speciﬁc impedance parameters. (a) Impedance spectroscopy-
pectrum PMS. (n¼3 experiments).
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differentiation enhancement
Morphologically, a 10 day application of micromolar DAPTFig. 6. Correlation of morphological, molecular with impedimetric data of DAPT-mediate
10 of DAPT treatment. Arrows mark neurons with distinct processes. (b) Immunocyt
(c) Quantitative gene and protein expression analysis of the neuronal differentiation m
correlation coefﬁcients of 2.5 mM DAPT-modiﬁed differentiation. (For interpretation of the
this article).concentrations induced a clear neuronal phenotype with long
neurites for all investigated precursors (Fig. 6a, arrows).
A more detailed visualization of molecular DAPT effects was
achieved by NF-L staining (Fig. 6b).d neuronal differentiation enhancement. (a) Morphological characterization at day
ochemical staining of the neuronal marker protein NF200 (green); scale 50 mm.
arker NF-L (n¼3 experiments), (d) analysis of time- and method-dependent data
references to color in this ﬁgure legend, the reader is referred to the web version of
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dependence of lt-NES and pNSC1 differentiation could be vali-
dated via NF-L staining not only at day 10 (Fig. 6b and c), but also
at day 5 (Supplementary Fig. S6c), when DAPT application led to a
high number of neurons with distinct processes that for native
differentiation was not visible before day 40 (Fig. 4b).
At early treatment days, even nanomolar DAPT concentrations
led to a differentiation status higher than in control cells for pNSC2
(Fig. 6b), which was also reﬂected in the NF-L gene expression
(Fig. 6c). Together with the impedance characteristics (Fig. 5a and
b), this again points on the high initial differentiation potential
that, independent of the DAPT concentrations, retains relatively
constant for prolonged differentiation periods. From day 10 on,
both precursor populations showed a comparable NF-L expression
indicating a common high differentiation state.
When analyzing DAPT-modiﬁed precursor marker gene and
protein expression, effects were clearly concentration-dependent
and an inhibition of progenitor marker could be observed for
micromolar concentrations within 20 days for all precursor lines
(Supplementary Fig. S6, Supplementary Fig. S7).
Finally, the correlation coefﬁcients for the impedimetric and
molecularbiological parameters were determined. Comparable to
the initial differentiation analysis, for lt-NES all three impedimetric
parameters and for the pNSC at least two impedimetric para-
meters showed high correlation (0.78oro1.00) to the NF-L pro-
tein expression (Fig. 6d, bold black boxes).
In summary, by applying DAPT treatment that is known to
accelerate the commitment of neural progenitors to neuronal
differentiation, we demonstrated that EIS analysis can be used to
quantitatively characterize the precursor's sensitivity for differ-
entiation modulators and sharply deﬁne the effective temporal as
well as concentration pattern.
Overall, the neuronal marker analysis was highly correlative to
the EIS-derived ﬁndings, and therefore validates our impedimetric
monitoring system and demonstrates the capability for the iden-
tiﬁcation and quantitative characterization of differentiation
accelerators.4. Discussion
In recent years, the potential of hiPS-derived neuronal cell
models for drug safety testing and pathology development were
discovered and implemented for Parkinson's (Zhao et al., 2014)
and Alzheimer's disease (Ooi et al., 2013), amyotrophic lateral
sclerosis (Richard and Maragakis, 2014) and neurotoxicity
screening (Scott et al., 2013).
However, a critical point that directly inﬂuences the sig-
niﬁcance and therewith, outcome of those in vitro neural networks
is the monitoring and qualiﬁcation of the differentiation process/
status in real-time – especially when considering the time (4one
month) invested to achieve mature neuronal networks. Most
studies on neuronal differentiation processes still rely on classical
qualitative or quantitative end-point analysis of neuronal marker
genes/proteins, which depend on time- and cost-consuming cell
labeling and destruction of the analyzed sample (Mertens et al.,
2015; Pasca et al., 2015), while electrophysiological analysis of
neuronal activity is only suitable for matured cultures after several
weeks/months (Heikkila et al., 2009; Mertens et al., 2015; Ullah
et al., 2016). Although, there is ongoing research to overcome
these limitations, existent studies as well require artiﬁcial hand-
ling such as cell isolation or genetic manipulation and are thus not
able to assure and predict the progress of neuronal maturation of a
complex iPS-derived neural network (Ilieva et al., 2013; Leao et al.,
2010; Mir and Shinohara, 2013).
In this study, non-invasive, label-free and high-sensitive EIStechnology was used to analyze neuronal differentiation processes.
EIS has been utilized already to distinguish initially differ-
entiated cells from their progenitors, but these studies concentrate
only on one single impedance parameter (resistance or capaci-
tance) and do not consider neuronal networks structures as well
as a sufﬁcient investigation period to qualitatively and quantita-
tively track the complete maturation process (Lee et al., 2014; Park
et al., 2011). Another approach proved that neurons, astrocytes and
their progenitors in suspension have different dielectric properties
suitable for cell sorting (Flanagan et al., 2008). However, this
method depends on single cell preparations destroying the native
neuronal network structure that establishes during the long-last-
ing maturation process.
In contrast, our study comprises the analysis of long-term
maturing neuronal networks based on multidimensional EIS
parameter and equivalent circuit modeling, which were identiﬁed
as signiﬁcant to describe the unique properties of neuronal net-
works or tissue (Jahnke et al., 2013a) and are closely correlated
with differentiation-speciﬁc cell molecularbiological and struc-
tural changes.
Therefore, our novel technology platform is speciﬁcally de-
signed for neuronal network monitoring. Microelectrode arrays
are comprised of densely arranged biocompatible gold electrodes
that guarantee the optimal temporal and spatial representation of
the developing neuronal cell morphology with its long processes
(axons, dendrites) and small cell body volume. To achieve long-
term stability, a highly polar, plasma-treated SU8 passivation was
applied that assures the generation of homogeneous neuronal
networks avoiding typical extensive neuron cell clustering (Klin-
shov et al., 2014; Teller et al., 2014). Importantly, the 96-well for-
mat of the multi-MEA allows an easy scale-up of the array and
therefore, the implementation of the technology platform in
standardized, automated assay-performing systems.
Reducing the needed time for differentiation would resolve a
critical problem for using hES-derived neuronal cultures in stan-
dardized assays. With our MEA-supported EIS platform, novel
differentiation/maturation accelerating compounds can be identi-
ﬁed. This capability was demonstrated by DAPT-mediated en-
hanced precursor-neuron transition (Theocharatos et al., 2013).
Furthermore, distinct effective temporal intervals for the DAPT
effect could be determined that are in explicit accordance with the
literature (Borghese et al., 2010).5. Conclusion
Taken together, we developed an EIS platform speciﬁcally de-
signed for quantitative precursor-speciﬁc neuronal network dif-
ferentiation monitoring that provides the capability for an easy
scale-up to industrial standardized 96-well plates. In this setting,
EIS can serve as a quality control instrument for the design and
optimization of neural stem/progenitor cell differentiation proto-
cols and therewith neuronal cultures before performing assays,
especially when combined to hybrid ﬁeld potential-based neuron
electrophysiology recording (Jahnke et al., 2013b). Subsequently,
the same measurement system can be applied for functional
pharmacological investigations e.g. neuro-developmental studies
of neurogenic and toxic compounds or drug screening in hiPS
disease modeling. To be meaningful in this context, the EIS-based
discrimination of neuron subtypes, i.e. dopaminergic for Parkin-
son's or cholinergic for Alzheimer's disease, is a subject of further
studies.
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